Methyl (1R,4S)-4-(tert-Butoxycarbonylamino)cyclopent-2-ene-1-carboxylate, 97%, 500mg

6-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-amine, 95.0%, 1g

H-Glu(OtBu)-Ome.HCl, 95%, 100g

(R)-2-(2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL)ACETIC ACID, 95%, 1g

(R)-Methyl 4-(1-aminoethyl)benzoate hydrochloride, 95.0%, 1g

2-Butanol, min. 98.5%, for synthesis, 500 ml, glass packaging

1-Bromo-2-pentyne, 97.0%, 5g

3-(Chlorosulfonyl)-4-iodobenzoic acid, 95%, 250mg

3-Ethoxy-5-(trifluoromethyl)aniline, 5g

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 3.00 µm, 1 Piece(s)

Tri-Boc-hydrazinoacetic acid, 98.0%, 5g

a-Cyclohexylphenylacetic acid, 98.0%, 100mg

N-(4-METHOXYPHENYL)ETHANETHIOAMIDE, 95.0%, 500mg